INTERNATIONAL PATENT: ALETHIA BIOTHERAPEUTICS INC. FILES APPLICATION FOR "COMBINATION THERAPY FOR NEOADJUVANT TREATMENT OF CANCER"

GENEVA, July 18 -- ALETHIA BIOTHERAPEUTICS INC. (141, President-Kennedy avenue,Suite SB-5100Montreal, Quebec H2X 1Y4) filed a patent application (PCT/CA2025/050032) for "COMBINATION THERAPY FOR NEOADJUVANT TREATMENT OF CANCER" on Jan 10, 2025. With publication no. WO/2025/147775, the details related to the patent application was published on Jul 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FILION, Mario (c/o ALETHIA BIOTHERAPEUTICS INC.141 President-Kennedy avenue,Suite SB-5100Montreal, Quebec H2X 1Y4), LAURIN, Julie (c/o ALETHIA BIOTHERAPEUTICS INC.141 President-Kennedy avenue,Suite ...